Luther StartUp Conference – Volume 6

Latest Posts

Partnering to unlock the true potential of cannabis in medical care

AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More

23

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

featured, Press release 2024

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...

Partex-NV-announces-collaboration-with-Althea-DRF-Lifesciences

28

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

featured, Press release 2024

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...

Innoplexus wins Horizon Interactive Gold Award for Curia App

Luther StartUp Conference – Volume 6

Luther StartUp Conference – Volume 6 will bring together panelists from Innoplexus, Capnamic Ventures, SIGNA Innovations, Capnamic, Signature Ventures among many others to discuss Venture Capital and its recent developments in Germany.

Gunjan Bhardwaj, CEO, and Founder of Innoplexus will be one of the renowned panelists.

When: 30th January 2020

Where: Musikbrauerei (music brewery) Berlin

Meet CEO and Founder of Innoplexus

Gunjan Bhardwaj
CEO and Founder – Innoplexus

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	The cookies are used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is used to store whether or not a user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Latest Posts

Partnering to unlock the true potential of cannabis in medical care

23

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

28

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Luther StartUp Conference – Volume 6

Meet CEO and Founder of Innoplexus

WHO WE ARE

WHAT WE OFFER

HOW WE WORK

WHY US

Updates

Frankfurt (Germany)

Pune (India)

Iselin (USA)

Cham (Switzerland)